About the journal
Oncotarget is an open-access journal published by Impact Journals LLC in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Impact Journals LLC
- ISSN
- 1949-2553
- Country
- United States
- Access
- Open access
Index listings
- MEDLINE · 2010-01-01
- PUBMED · 2014-01-15
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
27835
Last recorded publication year
2026
h-index
222
i10-index
21948
From OpenAlex open data (CC0).
Editorial & policy3
- Open references deposited at Crossref
- 62%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101532965
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- RNA modifications and cancer
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
Show all subjects (50)
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Circular RNAs in diseases
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer-related gene regulation
- Cancer-related gene regulation
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- RNA Research and Splicing
- RNA Research and Splicing
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Peptidase Inhibition and Analysis
- Peptidase Inhibition and Analysis
- Cancer Mechanisms and Therapy
- Cancer Mechanisms and Therapy
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- Histone Deacetylase Inhibitors Research
- Histone Deacetylase Inhibitors Research
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ